Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Oxycodone
OxyNorm
Routinely available
SMC (125/04)
29/03/2023
Indication
Moderate to severe pain in patients with cancer
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
Solution for injection
Comments
-